9 Stocks to Buy According to Billionaire Andreas Halvorsen’s Viking Global

Published February 22, 2022 at 11:21 am EST Updated August 19, 2026 at 7:07 am EDT

In this article, we discuss 9 stocks to buy according to billionaire Andreas Halvorsen’s Viking Global.

Norwegian billionaire Ole Andreas Halvorsen is the founding partner of Viking Global, and currently serves as the chief executive officer of the hedge fund.

Viking Global is a Connecticut-based hedge fund with a $34.4 billion Q4 13F portfolio, and it invests primarily in the industrials, healthcare, information technology, finance, consumer discretionary, and communications sectors.

Halvorsen holds an MBA from Stanford University, and his finance career began with Morgan Stanley (NYSE:MS)’s investment banking division. Soon after that, he joined Tiger Management, a hedge fund run by Julian Robertson, where Halvorsen worked in multiple roles, starting as an analyst. He was eventually promoted to the senior managing director, director of equities, and also became a member of the management committee.

Andreas Halvorsen is one of the Tiger Cubs who left Tiger Management to successfully start their own hedge funds. The billionaire focuses on long-term investments in public and private securities, and the most notable stocks from his fourth quarter portfolio include Microsoft Corporation (NASDAQ:MSFT), Meta Platforms, Inc. (NASDAQ:FB), and Tesla, Inc. (NASDAQ:TSLA).

Andreas Halvorsen of Viking Global

Our Methodology

We used the Q4 portfolio of Andreas Halvorsen to select the stocks for this analysis, ranking the securities according to the billionaire’s stake value in each holding.

Stocks to Buy According to Billionaire Andreas Halvorsen’s Viking Global

9. Parker-Hannifin Corporation (NYSE:PH)

Viking Global’s Stake Value: $972,468,000

Percentage of Viking Global’s 13F Portfolio: 2.81%

Number of Hedge Fund Holders: 39

Parker-Hannifin Corporation (NYSE:PH) is an Ohio-based company that specializes in motion and control technologies. Halvorsen’s Viking Global owned a $972.4 million stake in Parker-Hannifin Corporation in the fourth quarter of 2021, representing 2.81% of the fund’s 13F securities.

On January 27, Parker-Hannifin Corporation declared a $1.03 per share quarterly dividend, offering a forward yield of 1.33%. The dividend is payable on March 4, to shareholders of record on February 11.

Publishing its Q4 results on February 3, Parker-Hannifin Corporation announced earnings per share of $4.46, beating estimates by $0.53. Revenue for the quarter equaled $3.82 billion, up 12.10% year-over-year, exceeding estimates by $105.19 million.

Mizuho analyst Brett Linzey initiated coverage of Parker-Hannifin Corporation on December 16 with a Neutral rating and a $345 price target, stating that there is “plenty to like” about the company’s long-term outlook but not enough near-term upside to warrant a Buy rating.

Among the hedge funds tracked by Insider Monkey in the fourth quarter, one of the leading Parker-Hannifin Corporation stakeholders is Ric Dillon’s Diamond Hill Capital, with 1.4 million shares worth approximately $476.2 million. Overall, 39 hedge funds were bullish on the stock at the end of December 2021.

Just like Microsoft Corporation, Meta Platforms, Inc., and Tesla, Inc., Parker-Hannifin Corporation is one of the top stock picks of Viking Global.

Here is what Oakmark Funds has to say about Parker-Hannifin Corporation in their Q1 2021 investor letter:

“Parker Hannifin approached our estimates of intrinsic value and were, therefore, eliminated during the period. The company was a longstanding investment of the Fund and produced successful outcomes. We believe Parker Hannifin, one of our longest tenured positions, is a high-quality, well-managed industrial with strong competitive positions in good end markets. However, after the market price reflected these positives, we elected to sell to pursue more attractive alternatives that were priced at steeper discounts to our estimates of intrinsic value.”

8. Brookfield Asset Management Inc. (NYSE:BAM)

Viking Global’s Stake Value: $1,062,875,000

Percentage of Viking Global’s 13F Portfolio: 3.08%

Number of Hedge Fund Holders: 29

Brookfield Asset Management Inc. (NYSE:BAM) is one of the largest investment management companies in the world, headquartered in Toronto. Brookfield Asset Management Inc. invests primarily in real estate, renewable power, infrastructure, credit, and private equity.

Viking Global elevated its stake in Brookfield Asset Management Inc. by 4% in the fourth quarter, with 17.60 million shares worth $1.06 billion, representing 3.08% of the fund’s total 13F portfolio.

Brookfield Asset Management Inc. on February 10 declared a $0.14 per share quarterly dividend, a 7.7% increase from its prior dividend of $0.13. The dividend is payable on March 31, to shareholders of record on February 28.

The investment manager announced on December 17 that it had closed its flagship real estate debt fund, with capital commitments of over $4 billion, which will focus on lending against top-notch real estate assets in the US, the UK, and European metropolitan markets. The fund has made 15 investments to date, amounting to $700 million.

Brookfield Asset Management Inc. expects to raise over $15 billion for its impact fund, and the amount will be used for investments in utility and industrial companies that are looking to decarbonize. Brookfield Asset Management Inc. will also use the funds to build renewable sources of energy for industrial customers.

Deutsche Bank analyst Brian Bedell on February 11 raised the price target on Brookfield Asset Management Inc. to $64 from $59 and kept a Hold rating on the shares following the “strong” Q4 results.

Akre Capital Management is one of the leading stakeholders of Brookfield Asset Management Inc. as of Q4 2021, with a $792.6 million position in the company. Overall, 29 hedge funds were long Brookfield Asset Management Inc. in the fourth quarter.

Here is what Baron Funds has to say about Brookfield Asset Management Inc. in its Q2 2021 investor letter:

“The shares of long-term holding Brookfield Asset Management Inc. gained 15% in the most recent quarter. The company is a leading alternative asset manager focused on investing in high-quality real estate and infrastructure related assets that tend to generate predictable and growing cash flows. We remain bullish about the ongoing prospects for Brookfield given the secular growth opportunity for alternative assets, the company’s many competitive advantages including scale, global capabilities, its well known brand name, operating expertise, and performance track record. We hold management in high regard and believe the shares remain attractively valued.”

7. Adaptive Biotechnologies Corporation (NASDAQ:ADPT)

Viking Global’s Stake Value: $841,623,000

Percentage of Viking Global’s 13F Portfolio: 2.44%

Number of Hedge Fund Holders: 22

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is a commercial company engaged in the research, development, and distribution of immune-driven medicine. Viking Global owns roughly 30 million Adaptive Biotechnologies Corporation shares as of the fourth quarter of 2021, worth over $841.6 million, representing 2.44% of the fund’s total 13F securities.

Adaptive Biotechnologies Corporation announced its Q4 financial results on February 15, posting a loss per share of $0.43, exceeding estimates by $0.02. Revenue over the period jumped 25.66% year-over-year to $37.93 million, outperforming estimates by $1.08 million.

BTIG analyst Mark Massaro lowered the price target on Adaptive Biotechnologies Corporation on February 16 to $30 from $35 and kept a Buy rating on the shares. The company’s Q4 earnings were a “modest beat”, but its guidance was below consensus, albeit setting an “achievable bar”, the analyst told investors in a research note.

Among the hedge funds tracked by Insider Monkey, 22 funds were bullish on Adaptive Biotechnologies Corporation during Q4 2021, with stakes totaling $1.47 billion. Matrix Capital Management is one of the leading stakeholders of the company, with 11.5 million shares worth $324.7 million.

In addition to Microsoft Corporation, Meta Platforms, Inc., and Tesla, Inc., Adaptive Biotechnologies Corporation is one of the notable stocks from Andreas Halvorsen’s fourth quarter portfolio.

6. Microsoft Corporation (NASDAQ:MSFT)

Viking Global’s Stake Value: $986,347,000

Percentage of Viking Global’s 13F Portfolio: 2.86%

Number of Hedge Fund Holders: 262

Microsoft Corporation announced on December 21 that the European Union has approved its $16 billion bid to takeover Nuance Communications, Inc. (NASDAQ:NUAN), a speech recognition and AI software company that helped create Apple Inc. (NASDAQ:AAPL)’s virtual assistant, Siri. This acquisition will allow Microsoft Corporation to effectively offer cloud services to the healthcare sector.

Andreas Halvorsen’s Viking Global owns 2.9 million Microsoft Corporation shares as of December 2021, worth $986.3 million, representing 2.86% of the firm’s total investments.

Jefferies analyst Brent Thill raised the price target on Microsoft Corporation to $400 from $375 and kept a Buy rating on the shares on January 6. Despite a “massive 39% outperformance” versus the iShares Expanded Tech-Software Sector ETF in 2021 from Microsoft Corporation, he continues to see the potential in the stock as valuation provides downside protection.

Billionaire Ken Fisher’s Fisher Asset Management is a prominent Microsoft Corporation stakeholder from Q4 2021, with 26.8 million shares worth over $9 billion. Overall, 262 hedge funds reported owning stakes worth $75.6 billion in Microsoft Corporation in the fourth quarter.

Here is what ClearBridge Sustainability Leaders Strategy has to say about Microsoft Corporation in its Q3 2021 investor letter:

“The Strategy modestly outperformed the benchmark; consistent with our fundamental approach that seeks balanced exposure to industries and the growth and value spectrum, performance was driven by companies from diverse sectors. Microsoft, which develops software including the Windows family of products, the Microsoft Office system and the Azure cloud platform, and is a leader in data protection and customer privacy as well as human rights and diversity, contributed strongly as earnings maintained positive sentiment. Microsoft is seeing a number of businesses reach a new, higher level of engagement, adoption and momentum.”

5. Humana Inc. (NYSE:HUM)

Viking Global’s Stake Value: $1,235,430,000

Percentage of Viking Global’s 13F Portfolio: 3.58%

Number of Hedge Fund Holders: 66

Andreas Halvorsen, via Viking Global, holds 2.6 million shares of Humana Inc. (NYSE:HUM), worth $1.23 billion, representing 3.58% of the fund’s 13F portfolio. Humana Inc. is one of the largest American for-profit health insurance companies.

Humana declared on February 17 a $0.7875 per share quarterly dividend, a 12.5% increase from its prior dividend of $0.70. The dividend is payable on April 29, to shareholders of record on March 31.

The Defense Health Agency assigned Humana Inc. a $121.89 million contract on December 22, where the company will make changes to the Military Health System, as required by the 2017 National Defense Authorization Act.

Truist analyst David MacDonald on January 7 lowered the price target on Humana Inc. to $445 from $520 and kept a Hold rating on the shares. The analyst says his reduced price target reflects the company’s more conservative Medicare Advantage enrollment growth expectations and a lower assumed earnings multiple.

Humana Inc. announced its Q4 results on February 2, reporting earnings per share of $1.24, beating estimates by $0.08. The $21.05 billion revenue over the period missed estimates by roughly $231 million.

Among the 924 hedge funds tracked by Insider Monkey in the fourth quarter, 66 funds reported owning stakes in Humana Inc.. Harris Associates is the largest Humana Inc. stakeholder from Q4, with 4.4 million shares worth $2.05 billion.

Here is what Oakmark Equity and Income Fund has to say about Humana Inc. in their Q1 2021 investor letter:

“The third new purchase was Humana, the industry leader and near pure play in the fastest growing sector of managed care, Medicare Advantage. Each year, more seniors choose Medicare Advantage over traditional Medicare due to the compelling combination of lower costs and expanded benefits. Humana’s scale advantages and focus on senior care allow the company to make targeted investments in its members’ health, resulting in fewer unnecessary hospitalizations and lower chronic care costs. Much of these savings are then reinvested in the health plan, resulting in a continuously improving customer value proposition. The company’s brand also resonates well in the marketplace and has helped drive double-digit annual membership growth over the past decade—well above the rest of the industry. Further, we believe Humana has a long runway ahead as it benefits from an aging population and continued conversion of the approximately 60% of seniors who are still enrolled in traditional Medicare. Yet Humana’s shares are currently trading at a nearly 20% discount to the S&P 500 earnings multiple, which we believe doesn’t give the company enough credit for its durable competitive advantages and strong secular growth outlook.”

4. BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Viking Global’s Stake Value: $444,038,000

Percentage of Viking Global’s 13F Portfolio: 1.28%

Number of Hedge Fund Holders: 25

BridgeBio Pharma, Inc. (NASDAQ:BBIO), a biopharmaceutical company manufacturing drugs for genetic diseases and cancers, is one of the top stocks to buy according to billionaire Andreas Halvorsen’s Viking Global. The hedge fund holds a $444 million stake in BridgeBio Pharma, Inc. as of the fourth quarter of 2021, which accounts for 1.28% of the total 13F securities.

BridgeBio Pharma, Inc. announced on November 18 that it had gained non-dilutive debt financing of $750 million from a syndicate of lenders, which would allow BridgeBio Pharma, Inc. to fund its portfolio of more than 30 drug and discovery programs. To pursue commercialization of its drug pipeline and products, BridgeBio Pharma, Inc. now has access to over $1.2 billion, including cash balance and the debt financing.

25 hedge funds in Insider Monkey’s database of 924 elite funds were long BridgeBio Pharma, Inc. in Q4, with a total stake value of $799.4 million. Joseph Edelman’s Perceptive Advisors is one of the leading company stakeholders, with 7.1 million shares worth $118.90 million.

H.C. Wainwright analyst Raghuram Selvaraju on December 28 lowered the price target on BridgeBio Pharma, Inc. to $24 from $88 in light of one of the company’s drug trials failing, though he kept a Buy rating on the shares. Given the trial data, Selvaraju has decreased the probability of approval to 10% from 85%, while also lowering the peak penetration rate and pushing out the the timing of potential approval to 2024.

Here is what Baron Opportunity Fund has to say about BridgeBio Pharma, Inc. in its Q2 2021 investor letter:

“BridgeBio Pharma, Inc. is a biotechnology company developing drugs that address a host of genetic disorders. Shares fell in the quarter given concerns around increasing competition. While we expect positive results from BridgeBio’s Phase 3 trial for its lead program for TTR amyloidosis, a disease in which toxic proteins build up in the heart and nerves, encouraging updates from Alnylam’s competing drug, Vitrusiran, and more recently, Intellia’s gene editing platform, pressured the stock. We exited our position.”

3. T-Mobile US, Inc. (NASDAQ:TMUS)

Viking Global’s Stake Value: $1,524,938,000

Percentage of Viking Global’s 13F Portfolio: 4.42%

Number of Hedge Fund Holders: 86

T-Mobile US, Inc. (NASDAQ:TMUS) is the second largest American wireless network operator, partly owned by the German telecommunications company, Deutsche Telekom. Viking Global added 29% to its existing position in T-Mobile US, Inc. during the fourth quarter, holding a total of 13.1 million shares, worth $1.5 billion, representing 4.42% of the firm’s 13F portfolio.

T-Mobile US, Inc. reported on January 6 that the Q4 new customer count totaled 1.8 million, as compared to estimates of 1.57 million new customers, bringing the company’s total customers to 108.7 million.

To improve its financial synergies and lay out an extensive 5G network around the United States, T-Mobile US, Inc. announced on January 6 that it has signed a 12 year contract with Crown Castle International Corp. (NYSE:CCI), which will allow T-Mobile US, Inc. access to telecom towers and small cell locations.

Publishing its Q4 results on February 2, T-Mobile US, Inc. reported earnings per share of $1.10, exceeding estimates by $1.01.

Daiwa analyst Jonathan Kees initiated coverage of T-Mobile US, Inc. on December 23 with a Neutral rating and a $128 price target. T-Mobile US, Inc. has been integrating an older company and execution risks remain high, and the market for 5G network is quite competitive.

Berkshire Hathaway is one of the leading T-Mobile US, Inc. stakeholders from the 86 hedge funds that were bullish on the stock during the fourth quarter. Warren Buffet’s fund holds 5.2 million T-Mobile US, Inc. shares worth approximately $670 million.

Here is what ClearBridge Investments has to say about T-Mobile US, Inc. in its Q1 2021 investor letter:

“The portfolio’s quality bias and valuation discipline have generated compelling returns over time with typically strong relative results in more challenging environments as it did through the first three quarters of 2020. However, that same quality bias tends to create a more challenging relative performance environment for the Strategy during periods of sharp economic acceleration, which tend to benefit stocks that are more commodity linked or of lower quality. This has been the case during the vaccine- and stimulus-driven rally experienced late last year and during the most recent quarter. Sectors that lagged in the quarter included communication services, where T-Mobile trailed after generating robust returns earlier in the recovery.”

2. General Electric Company (NYSE:GE)

Viking Global’s Stake Value: $1,704,348,000

Percentage of Viking Global’s 13F Portfolio: 4.94%

Number of Hedge Fund Holders: 57

General Electric Company (NYSE:GE) was a new arrival in Andreas Halvorsen’s Viking Global’s portfolio in Q3 2021, and the hedge fund increased its position in the company by 7% in the fourth quarter, holding more than 18 million shares, worth $1.70 billion, representing 4.94% of the total Q4 investments. General Electric Company is an American multinational company focused on the aviation, power, renewable energy, and digital sectors.

On December 10, General Electric Company announced a $0.08 per share quarterly dividend, in line with previous. The dividend was paid on January 25, to shareholders of record on December 21, 2021.

General Electric Company disclosed that it is set to acquire Opus One Solutions Energy, a Canada-based software company helping electric utilities optimize their energy consumption, planning, and market management. The acquisition will enable General Electric Company to get on board with rapid adoption of renewables and distributed energy resources.

Credit Suisse analyst John Walsh upgraded General Electric Company on January 4 to Outperform from Neutral with a $122 price target. The company is separating into three public companies: Energy, Aviation, and Healthcare, and the analyst believes the recent selloff in the shares presents an opportunity to get positive.

Among the hedge funds tracked by Insider Monkey, 57 funds were bullish on General Electric Company in the fourth quarter. Pzena Investment Management is one of the leading General Electric Company shareholders as of December 2021, with a stake worth over $1 billion.

Here is what Vulcan Value Partners has to say about General Electric Company in its Q3 2021 investor letter:

“During the quarter, we sold our positions in General Electric Co. General Electric is a company we followed for a long time. In the past, we removed GE from the MVP list due to management’s poor capital allocation decisions which resulted in value instability. Larry Culp, the former CEO of Danaher, became CEO of General Electric in 2018. The company implemented a vast restructuring program to simplify the industrial side of its business, sold off non-core assets, paid down debt with the proceeds, and drastically shrunk GE Capital. These restructuring activities allowed its world-class jet engine and healthcare businesses to shine through, and improved value stability. As a result, we added the company back to the MVP list. While the pandemic negatively impacted General Electric’s aviation business in the short run, it also gave us the opportunity to buy General Electric in the second quarter of 2020 with a substantial margin of safety. GE is a good example of a competitively entrenched, yet slower growing MVP business. As its stock price rose rapidly over the last year, its value growth did not keep up, and the price to value gap closed quickly. As our margin of safety diminished, we sold our position in GE and allocated it to more discounted companies.”

1. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Viking Global’s Stake Value: $2,592,479,000

Percentage of Viking Global’s 13F Portfolio: 7.51%

Number of Hedge Fund Holders: 30

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a biotech company based in Massachusetts, specializing in genetics engineering, producing bacteria with industrial applications.

Andreas Halvorsen’s Viking Global held a $2.59 billion stake in Ginkgo Bioworks Holdings, Inc. during the fourth quarter of 2021, which represents 7.51% of the fund’s total 13F securities. Ginkgo Bioworks Holdings, Inc. is the largest holding in Viking Global’s Q4 portfolio.

BTIG analyst Mark Massaro on January 6 initiated coverage of Ginkgo Bioworks Holdings, Inc. with a Buy rating and a $12 price target. McKinsey estimates that the global market for bioengineered, or “synthetic biology” products like those pursued by Ginkgo Bioworks Holdings, Inc. may reach $2 trillion to $4 trillion annually by 2040 and $3 trillion to 5 trillion by 2050.

Among the 924 hedge funds tracked by Insider Monkey in Q4 2021, 30 funds reported owning stakes worth $4.2 billion in Ginkgo Bioworks Holdings, Inc..

You can also take a look at 10 Micro-Cap Stocks to Buy According to Cathie Wood and 10 Cheap Growth Stocks to Buy According to Billionaire Steve Cohen.

Follow Insider Monkey on Twitter